Previous studies captured the CH mutations in peripheral blood cells and whole bone marrow, while how these mutations accumulate in the B cell lineage and, finally, the myeloma cells remains largely unexplored [25–28]. This evidence concerns the gene C4B and plasma cell myeloma.